August 7, 2013 / 1:25 PM / 4 years ago

Valeant sees smaller deals, discussing merger of equals

1 Min Read

Aug 7 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, continues to discuss a potential merger of equals, and also expects to be active for the rest of 2013 with smaller acquisitions, Chief Executive Michael Pearson said.

Completing a merger of equals "can't be predicted," Pearson said on Wednesday during a conference call to discuss second-quarter results.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below